(Q42985488)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Khalifa E Khalifa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Alaa Ismail

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Camilla S Graham

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Qi He

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jens W Rasenack

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Thomas Peters

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ahmed A Tawil

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jutta J Fehr

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Mahmoud M Madwar

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Margaret James Koziel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1721-1731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

29 December 2019

cites work

1 reference

Interferon therapy for acute hepatitis C viral infection--a review by meta-analysis

21 January 2018

1 reference

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

21 January 2018

1 reference

7 January 2021

The natural history of hepatitis C-A quandary

1 reference

7 January 2021

Treatment of acute hepatitis C with interferon alfa-2b

1 reference

7 January 2021

High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study

1 reference

7 January 2021

Resolution of acute hepatitis C after therapy with natural beta interferon

1 reference

7 January 2021

A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C.

1 reference

7 January 2021

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

7 January 2021

Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C

1 reference

7 January 2021

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

1 reference

7 January 2021

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

1 reference

7 January 2021

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

7 January 2021

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

1 reference

7 January 2021

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome

1 reference

7 January 2021

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

7 January 2021

Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

1 reference

7 January 2021

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

1 reference

7 January 2021

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

1 reference

7 January 2021

Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination

1 reference

7 January 2021

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

1 reference

7 January 2021

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15185314%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference